Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 13/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 13/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 12/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 10/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 5/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 14/20 | 0.81 |
| ▸ | TP53 | P04637 | 9/20 | 0.81 |
| ▸ | LMNA | P02545 | 4/20 | 0.81 |
| ▸ | PKM | P14618 | 2/20 | 0.81 |
| ▸ | CA12 | O43570 | 1/20 | 0.81 |
| ▸ | CA1 | P00915 | 1/20 | 0.81 |
| ▸ | CA2 | P00918 | 1/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.81 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2746872 | 0.95 | MEN1 (0.90) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL27595696 | 0.92 | KDM4E (0.90) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Chrysene SCHEMBL29180387 | 0.90 | CYP3A4 (0.81) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| SCHEMBL76636 | 0.90 | KDM4E (0.93) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL1679068 | 0.90 | KDM4E (1.00) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL29433939 | 0.90 | KDM4E (1.00) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL20246 | 0.90 | KDM4E (1.00) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL31570209 | 0.88 | KDM4E (0.97) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL31328341 | 0.88 | KDM4E (0.97) | MEN1KMT2ACYP3A4HSD17B10MAPK1 | |
| Flavonol SCHEMBL21874433 | 0.88 | KDM4E (0.97) | MEN1KMT2ACYP3A4HSD17B10MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604294-A | ERbeta estrogenic compounds and methods of use | 益特瑞恩公司 | 2025-03-11 | — | — | CN | claimed |
| CN-115032256-B | Method for distinguishing chrysin and isomer 3,4' -dihydroxyflavone thereof | 安徽大学 | 2024-04-02 | — | — | CN | claimed |
| US-20230003721-A1 | MITOTHERAPEUTICS FOR THE TREATMENT OF BRAIN DISORDERS | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2023-01-05 | — | — | US | claimed |
| CN-115032256-A | Method for distinguishing chrysin and isomer 3, 4' -dihydroxyflavone thereof | 安徽大学 | 2022-09-09 | — | — | CN | claimed |
| US-20200123673-A1 | ELECTROLYTIC TIN ALLOY PLATING SOLUTION | C. UYEMURA & CO., LTD. (JP) | 2020-04-23 | — | — | US | claimed |
| WO-2019198962-A1 | METHOD FOR PROMOTING PROLIFERATION AND DIFFERENTIATION OF INDUCED PLURIPOTENT STEM CELLS PREPARED FROM URINE-DERIVED STEM CELLS | 건국대학교 산학협력단 | 2019-10-17 | — | — | WO | claimed |
| US-7897637-B2 | Methods of using flavonoids to enhance memory | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2011-03-01 | — | — | US | claimed |
| WO-2008011538-A2 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2008-01-24 | — | — | WO | claimed |
| US-20080021096-A1 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2008-01-24 | — | — | US | claimed |
| US-12534742-B2 | Compound for regulating gene editing efficiency and application thereof | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2026-01-27 | — | — | US | disclosed |
| US-20250263774-A1 | DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD | UNIV NORTH TEXAS (US) | 2025-08-21 | — | — | US | disclosed |
| US-12368049-B2 | Protective film agent and processing method of workpiece | DISCO CORPORATION (JP) | 2025-07-22 | — | — | US | disclosed |
| US-20250195452-A1 | ER-BETA ESTROGENIC COMPOUNDS AND METHODS OF USE | IATERION, INC. | 2025-06-19 | — | — | US | disclosed |
| EP-4561582-A1 | ER-BETA ESTROGENIC COMPOUNDS AND METHODS OF USE | Iaterion, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2008011538-A2 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2008-01-24 | — | — | WO | disclosed |
| EP-1856085-A1 | FLAVONOID COMPOUNDS AND USES THEREOF | Howard Florey Institute of Experimental Physiology and Medicine (AU) | 2007-11-21 | — | — | EP | disclosed |
| US-20070254859-A1 | Compounds exhibiting efflux inhibitor activity and composition and uses thereof | EASTMAN CHEMICAL COMPANY | 2007-11-01 | — | — | US | disclosed |
| WO-2007115181-A2 | COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007082178-A2 | PROSTAGLANDIN REDUCTASE INHIBITORS | ABGENOMICS CORPORATION (TW) | 2007-07-19 | — | — | WO | disclosed |
| WO-2006094357-A1 | FLAVONOID COMPOUNDS AND USES THEREOF | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2006-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254859-A1 | Compounds exhibiting efflux inhibitor activity and composition and uses thereof | ABCC4, NCOA4, NR4A3 | MEN1 4281/4885KMT2A 4362/4885CYP3A4 17/4885 |
| US-20250195452-A1 | ER-BETA ESTROGENIC COMPOUNDS AND METHODS OF USE | ESR2, ESR1, ESRRB | MEN1 2127/4885KMT2A 4051/4885CYP3A4 210/4885 |
| US-20080021096-A1 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | FOS, CREBBP, CREB1 | MEN1 3520/4885KMT2A 1152/4885CYP3A4 4468/4885 |
| US-12534742-B2 | Compound for regulating gene editing efficiency and application thereof | ERG, APOBEC3A, APOBEC3C | MEN1 2980/4885KMT2A 799/4885CYP3A4 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.